OriGene Technologies, Inc.
Search:    
Left ProductsProducts divider ServicesServices divider technologyTechnology divider researchResearch divider TechsupportTechSupport divider AboutAbout Right

Webinar on Cancer Biomarker
Cancer Biomarker Webinar

OriGene TissueScan in recent publications
Role of MYC-Regulated Long Noncoding RNAs in Cell Cycle Regulation and Tumorigenesis J. Natl. Cancer Inst. Apr 2015 [Tissues]

Comparison of custom capture for targeted next-generation DNA sequencing J Mol Diagn Jan 2015 []

Comparison of custom capture for targeted next-generation DNA sequencing J Mol Diagn Jan 2015 []

Comparison of custom capture for targeted next-generation DNA sequencing J Mol Diagn Jan 2015 []

Protein Lysate (150µg); Lymph node; Malignant melanoma, metastatic

Specifications Related Products Research Agreement FAQs
Catalog No. Description Price Shipping
CP609734 Protein Lysate (150µg); Lymph node; Malignant melanoma, metastatic $ 280 3 days
<< Back to Search Result   Add to Shopping Cart
Disease StateCancer
Diagnosis CategoryMalignant melanoma
TissueLymph node
Case IDCU0000001521
PrepNot applic
Vial IDFR00005726
Frozen Sample IDFR00005726
Tissue of OriginSkin
Site of FindingLymph node
AppearanceTumor
Sample Diagnosis (from Pathology Verification)Malignant melanoma, metastatic
Normal0%
Lesional0%
Tumor90%
Tumor Hypo/Acellular Stroma5%
Tumor Hypercellular Stroma5%
Necrosis0%
Pathology Verification notes from H&E review
Bioanalyzer Ratio (28S/18S)
CASE Diagnosis (from medical center path report)Malignant melanoma, metastatic
Age61
GenderMale
Race
Tumor GradeNot Reported
Minimum Stage GroupingIIIB
T (Extent of Primary Tumor) TX
N (Lymph node metastasis) N2b
M (Distant metastasis)MX
Diagnostic Test ResultsCytokeratins (5 and 6) ~ CK5,6 ! by IHC,Negative. MART-1 ~ Melanoma Marker ~ Melan-A,Positive. Vimentin ~ VIM ! by IHC,Positive. S100 protein,Positive

 

pattern
Inc 5000 Healthcare Company
All Products by: Title | Price | Category | Popularity | Best Sellers Topselling Products by: Title | Price | Category | Popularity | Favorites
Popular Categories: Popularity | Our Choices | All-Round Favorites | Title Topselling Categories: Popularity | Our Choices | All-Round Favorites | Title